TDOC Form 144: June 2026 sales of 10,179 shares

TDOC filed Form 144 reporting sales and recent restricted‑stock vesting for Common stock.

Rhea-AI Filing Summary

TDOC filed Form 144 reporting sales and recent restricted‑stock vesting for Common stock. The filing lists restricted stock vesting of 118 shares on 03/19/2025 and 2,382 shares on 06/01/2025. It also reports sales of 7,679 shares for $58,567.73 on 06/02/2026 and 2,500 shares for $21,250.00 on 06/29/2026.

Insights

Securities Compliance Specialist

Routine Form 144 sale notices and recorded restricted‑stock vesting are shown with specific dates and amounts.

The filing lists restricted stock vesting events on 03/19/2025 (118 shares) and 06/01/2025 (2,382 shares), and two reported sales in June 2026 totaling 10,179 shares. These items align with typical disclosure mechanics for Form 144 filings.

Cash‑flow recipients and holder identities beyond the listed broker and named seller are shown in the excerpt; further investor implications depend on broader holdings data outside this excerpt.

Key Figures

June 2, 2026 sale: 7,679 shares June 29, 2026 sale: 2,500 shares Restricted stock vesting (Mar 2025): 118 shares +3 more

6 metrics

June 2, 2026 sale 7,679 shares sale recorded on 06/02/2026 for $58,567.73

June 29, 2026 sale 2,500 shares sale recorded on 06/29/2026 for $21,250.00

Restricted stock vesting (Mar 2025) 118 shares Restricted Stock Vesting on 03/19/2025

Restricted stock vesting (Jun 2025) 2,382 shares Restricted Stock Vesting on 06/01/2025

Total shares shown 10,179 shares Aggregate of two reported June 2026 sales in the excerpt

Sale proceeds shown $79,817.73 Sum of reported proceeds $58,567.73 and $21,250.00

Key Terms

Form 144, Restricted Stock Vesting, Fidelity Brokerage Services LLC, Securities To Be Sold

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 118 | 03/19/2025"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Fidelity Brokerage Services LLC other

"Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TDOC disclose in the Form 144 filing?

TDOC disclosed restricted stock vesting and two reported share sales with amounts and dates. The excerpt shows vesting of 118 shares on 03/19/2025 and 2,382 shares on 06/01/2025, plus reported sales of 7,679 and 2,500 shares in June 2026.

How many shares were reported sold in the TDOC Form 144?

The filing reports sales totaling 10,179 shares across two transactions. Specifically, 7,679 shares on 06/02/2026 for $58,567.73 and 2,500 shares on 06/29/2026 for $21,250.00.

Does the Form 144 show recent restricted stock vesting for TDOC?

Yes — the excerpt records two restricted‑stock vesting events in 2025. The entries list 118 shares vesting on 03/19/2025 and 2,382 shares vesting on 06/01/2025 under 'Restricted Stock Vesting' with Issuer as the source.

Who is named as the broker or intermediary in the filing?

Fidelity Brokerage Services LLC is listed as a broker in the excerpt. The broker entry shows an address and the NYSE venue; the excerpt pairs Fidelity with a securities line but does not expand on execution details.

What dollar amounts are shown for the June 2026 sales?

The June 2026 sales are shown as $58,567.73 and $21,250.00. These correspond to 7,679 shares sold on 06/02/2026 and 2,500 shares sold on 06/29/2026, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 02:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002036989
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Bliss Kelly
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2500	22500.00	180513087	07/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/19/2025	Restricted Stock Vesting	Issuer			118	03/19/2025	Compensation
Common	06/01/2025	Restricted Stock Vesting	Issuer			2382	06/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kelly M. Bliss 155 E 44th Street Suite 1700 New York NY 10017	Common	06/02/2026	7679	58567.73
Kelly M. Bliss 155 E 44th Street Suite 1700 New York NY 10017	Common	06/29/2026	2500	21250.00

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kelly M. Bliss
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)